NATNAT: Newly Adapted Tools and Network Against Mosquito Borne Disease Transmission
Burnet is partnering to reduce malaria and mosquito-borne diseases in Papua New Guinea (PNG). By generating local evidence, and strengthening leadership and advocacy, we’re driving access, uptake and impact of new vector control tools in PNG and the Pacific.
Our impact
14 novel vector control products tested across priority categories in lab, semi-field or field studies.
Designed and constructed the Belna Natnat Centre, a new research facility for mosquitos and malaria.
Established the PNG-led Vector Control Network to enhance coordination, foster partnerships and drive access and uptake of VCTs.
In short
Malaria transmission has been on the rise in PNG and Solomon Islands in recent years.
NATNAT is a partnership to respond, led by the Papua New Guinea Institute of Medical Research (PNGIMR) and the National Malaria Control Program. Our work focuses on vector control tools – tools we can use to control mosquitos, the ‘vectors’ that transmit malaria. Building on 7 years of impact, our work includes:
-
evaluating new vector-control tools that are complementary to insecticide-treated nets (ITNs)
-
strengthening vector control tool research in PNG
-
building partnerships and collaborations through the PNG-led Vector Contol Network.
From discovery in labs to delivery in the field, we're supporting the fight against malaria and other vector-borne diseases in PNG, strengthening health systems in the Pacific region for the future.
How NATNAT addresses gaps in protection
Insecticide-treated bed nets are currently the only vector control intervention distributed nationally in PNG to reduce the risk of mosquitos biting and transmitting malaria.
Research conducted by the PNGIMR shows that mosquitos in PNG often bite people outdoors and during early evening hours, when they are not protected by insecticide-treated nets. This is a critical gap in malaria prevention in PNG.
The NATNAT project is investigating additional vector control tools, to evaluate how effective and suitable they are in the PNG context.
Dr John Bosco Keven, Postdoctoral Researcher at PNGIMR, conducting research on local mosquitos.
What we're doing
From 2024 to 2028, we’re evaluating the use of spatial emanators as a way to control the spread of malaria by mosquitos. This builds on our previous work looking at different ways to reduce malaria, including:
-
spraying long-lasting insecticides (residual spraying)
-
reducing breeding sites (larval source management).
To evaluate spatial emanators, we’re running studies across PNG, working in both labs (semi-field studies) and in communities.
Tap an image to expand it in focused view
Spatial emanators hanging in different settings.
Using spatial emanators to fight malaria
Spatial emanators are small insecticide-filled plastic cassettes that hang on the wall or from the ceiling. They are made of fabric and plastic, and don’t need electricity, flames or batteries to work. Instead, they passively emit chemicals that affect mosquitos, disorienting, repelling or killing them. Spatial emanators are the first new category of vector control tool that has been recommended for use by the World Health Organization in several decades.
Like insecticide-treated nets, spatial emanators are approved for indoor use. But in PNG, many people live outdoor-centred lifestyles. We want to test whether they can work outdoors to reduce malaria. Their effectiveness could depend on the location, housing structure, how people behave and move, and different mosquito behaviours.
Through the NATNAT project, we have evaluated several spatial emanator products in laboratory, semi-field and field studies.
In one entomological field study, our results showed that SC Johnson Guardian spatial emanators reduced mosquito biting when deployed in both outdoor and indoor settings (M. Katusele, manuscript in preparation).
-
Outdoors: 50–60% reduction in Anopheles mosquito biting for up to 6 months.
-
Indoors: 70–80% reduction in Anopheles mosquito biting at approximately 8 to 9 months after deployment.
As part of our WinMal trial, we’re building on those studies to understand whether GuardianTM can reduce malaria infection risk in PNG communties.
The WinMal trial
The WinMal trial is a large-scale cluster randomised control trial investigating whether spatial emanators reduce transmission of malaria infections. The study is being conducted with 150 rural villages in Bogia, Sumkar, Madang and Rai Coast districts of Madang Province, Papua New Guinea.
The trial will address the question: 'Do Guardian spatial emanators reduce malaria transmission when deployed in protected outdoor spaces or inside houses in PNG?'
The trial will evaluate the effectiveness, acceptability and feasibility of Guardian SE deployed indoors and outdoors for malaria prevention in PNG.
The WinMal trial will provide evidence to guide PNG National Department of Health decisions on how spatial emanators could be deployed alongside ITNs to address gaps in protection from outdoor biting.
More work we're doing
-
Testing spatial emanators indoors and outdoors through a series of parallel studies in the Pacific Experimental Huts at the Belna Natnat Centre.
-
Evaluating how well they work against different types of mosquitos through bioefficacy monitoring.
-
Measuring coverage, attrition and durability of spatial emenators during the WinMal trial.
-
Monitoring any possible impact of spatial emanators on insecticide resistance in mosquitoes.
- Understanding community experiences, perspectives and acceptability of vector control tools through qualitative research (interviews and focus group discussions).
- Using the Photovoice method to explore how spatial emanators impact community behaviours and experiences.
- Conducting interviews with health system stakeholders to assess pathways and readiness for implementation of vector control tools.
-
Exploring the cost of these vector control approaches.
-
Conducting cost-effectiveness analysis and budget impact analysis of VCTs.
-
Understanding what people are willing to pay for different VCTs.
-
Implementing quality management systems at the Belna Natnat Centre (BNC) mosquito research facility.
-
Expanding the research that can be conducted at BNC by adding a new species of mosquito (Aedes aegypti) to the insectary.
Continue to facilitate and empower the PNG Vector Control Network – a network of national, provincial, private-sector, NGO and research partners to share knowledge, resources and to advocate for increased investment in vector control in PNG.
Rearing colony mosquitos at the PNGIMR Belna Natnat Centre in Madang.
What we've done
From 2020 to 2023, we built the foundation for the trials and studies we’re doing now.
Built the PNGIMR Belna Natnat Centre, a research facility that examines mosquitos in the lab and supports local field work.
- Tested residual spraying with villages.
- Evaluated larvicides that kill young mosquitos.
- Evaluated 2 spatial emanator products.
- Implementing quality management systems to the Belna Natnat Centre (BNC) mosquito research facility.
- Trained communities on how to use sprays and other tools.
- Recruited staff and supported PhD student projects.
Talked to communities and providers about what works best for them (qualitative research and acceptability).
Brought together the Vector Control Network.
About the name
This project is named ‘Natnat’ which is the Tok Pisin word for mosquito. NATNAT is also an acronym that stands for ‘Newly adapted tools and network against mosquito-borne disease transmission.’
Reports
-
Gender equality, disability and social inclusion in vector-borne disease implementation and health systems strengthening programs
NATNAT is informed by a gender equality, disability and social inclusion (GEDSI) analysis of the STRIVE, ADVANCE and NATNAT projects, which guides our approach to promoting equitable opportunities and conducting inclusive research.
Gender equality, disability and social inclusion in vector-borne disease programs
Publications
Efficacy of Metofluthrin Spatial Emanators to Reduce Human Vector Contact in Papua New Guinea
The Journal of Infectious Diseases
Michelle Katusele et al
Understanding community and health system acceptability, readiness and perspectives on the introduction of new vector control approaches for malaria control in Papua New Guinea
Malaria Journal
Zebedee Kerry et al
Insecticidal efficacy of residual spraying with deltamethrin–clothianidin (Fludora® Fusion) in Papua New Guinea
Parasites & Vectors
Evodia Anetul et al
Partners
Funding partners
Supported by the Australian Government through the Department of Foreign Affairs and Trade’s Indo-Pacific Centre for Health Security, and the Innovative Vector Control Consortium (IVCC.
Collaborators
- Papua New Guinea Institute of Medical Research
- James Cook University, Australia
- Innovative Vector Control Consortium
- National Department of Health National Malaria Control Program
- Madang Provincial Health Authority, Papua New Guinea
- Swiss Tropical and Public Health Institute, Switzerland
- Rotarians Against Malaria, Australia
- SC Johnson (SCJ)
- Ifakara Health Institute (IHI), Tanzania
- The University of Melbourne, Australia
Project contacts
Professor Leanne Robinson
Deputy Director for International; Program Director, Health Security and Pandemic Preparedness; Senior Principal Research Fellow; Head, Vector-Borne Diseases and Tropical Public Health
Project team
Professor Leanne Robinson
Principal Investigator
Moses Laman
Principal Investigator
Papua New Guinea Institute of Medical Research
Associate Professor Stephan Karl
Principal Investigator
Asia-Pacific Centre of Excellence in Malaria Research in PNG
Dr Maria Ome-Kaius
Principal Investigator
Papua New Guinea Institute of Medical Research
Dr Jacob Kisomb
Principal Investigator
Papua New Guinea National Department of Health
Paul Daly
Senior Research Officer and Project Manager
Annie Dori
Senior Partnership Manager
John Bosco Keven
Postdoctoral Researcher and WinMal Study Lead
Papua New Guinea Institute of Medical Research
Petrina Johnson
Senior Entomologist
James Cook University, Papua New Guinea Institute of Medical Research
Rachael Farquhar
Senior Research Officer